common.study.topics.clinical

Biopsy in Chronic Hepatitis B

common.study.values.description

“Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:”

The objective of this study is to identify immunological mechanisms that contribute to normalization of liver inflammation in chronic hepatitis B (CHB) patients starting the antiviral nucleoside analogue, Tenofovir alafenamide (TAF).

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Recruiting patients only common.study.methods.is-healthy-yes

Drug - Tenofovir Alafenamide

TAF 25mg once daily orally, for 48 weeks

participant.views.study.view.additional

participant.views.study.view.scientific-title

Evaluation of Intrahepatic Immune and Virological Response to Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B: an Investigator-Initiated, Cohort Study

common.study.values.clinical-trial-id

NCT04070079

participant.views.study.view.id

b4x0nb